EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Do-it-yourself game plans

Stage 1: How do you define what the clinic is buying?

Dose Diligence research deskSection 02 · Page 3 of 17Last updated 17 Nov 2026

Write a one-page procurement charter before contacting suppliers. Keep patient treatment choices separate from commercial route selection.

What belongs in the charter?

Record:

  • Current and intended states, locations and prescriber count.
  • Current products and presentations, approved by clinical leadership for evaluation.
  • Active patients, expected new starts and prescriptions due by product and state.
  • Insurance-covered, self-pay and other access cohorts.
  • Existing contracts, renewal dates, minimums, deposits and termination notice periods.
  • The decision deadline and why the project exists.
  • Whether the clinic purchases medicines, pays service fees, recommends pharmacies or controls prescription routing.
  • The current failure baseline: unresolved prescriptions, delivery exceptions, refunds and staff handling time.

Use aggregate or appropriately de-identified information in procurement files. Keep patient-identifiable records in approved clinical systems, not in supplier-comparison spreadsheets or general-purpose research uploads.

How should you separate the money flows?

Use this proposed ledger structure:

LedgerExamples to recordWhat to establish
Clinic-controlled expenditurePurchased stock; software; integration; staff handling; service feesCan the clinic actually negotiate or remove it?
Patient expenditureMedicine payment; shipping; supplies; separate care membershipWho collects it, and under what eligibility conditions?
Payer expenditureReimbursed medicine and dispensing amountsIs the figure evidenced by actual adjudication or merely estimated?
Contingent exposureDeposits; guarantees; minimum commitments; termination chargesWhat remains payable after a service or regulatory interruption?

Do not book patient medicine savings as clinic margin. A lower pharmacy price benefits the clinic financially only through an identified contractual or operational mechanism; model that mechanism rather than assuming it.

Should all patients follow the same access route?

Do not start with that assumption. Build separate coverage and self-pay workflows, then let the clinical and access teams determine the appropriate options for each cohort.

For example, CMS describes the Medicare GLP-1 Bridge as a demonstration operating from July 1, 2026, through December 31, 2027, outside the usual Part D coverage and payment flow, with a central processor managing prior authorisation, claims and pharmacy payment in 2026. Clinics serving Medicare patients should investigate eligibility rather than automatically placing everyone into a manufacturer cash-pay workflow. CMS programme overview. (cms.gov)

Stage 1 exit document: a charter specifying the route decisions, patient cohorts, negotiable expenditure and baseline performance.

Explore the table row by row

A working view of the research

Clinic-controlled expenditure

Examples to record
Purchased stock; software; integration; staff handling; service fees
What to establish
Can the clinic actually negotiate or remove it?

Answers stay in this session unless you choose to save. No account needed.

Sources cited on this page

  1. cms.gov · Source 1 ↗https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
Section sources →